{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:08:26Z","timestamp":1783944506825,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2005,5,19]],"date-time":"2005-05-19T00:00:00Z","timestamp":1116460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,5,19]],"date-time":"2005-05-19T00:00:00Z","timestamp":1116460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2005,9,1]]},"DOI":"10.1038\/sj.jhh.1001877","type":"journal-article","created":{"date-parts":[[2005,5,19]],"date-time":"2005-05-19T12:32:41Z","timestamp":1116505961000},"page":"737-743","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Efficacy and safety of sibutramine in 2225 subjects with cardiovascular risk factors: short-term, open-label, observational study"],"prefix":"10.1038","volume":"19","author":[{"given":"Z","family":"Gaciong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Placha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for Polish Sibutramine Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,5,19]]},"reference":[{"key":"BF1001877_CR1","doi-asserted-by":"crossref","unstructured":"The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure: the trials of hypertension prevention, phase II. Arch Intern Med 1997; 157: 657\u2013667.","DOI":"10.1001\/archinte.157.6.657"},{"key":"BF1001877_CR2","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s11906-001-0030-x","volume":"3","author":"AM Sharma","year":"2001","unstructured":"Sharma AM, Engell S, Pischon T . New developments in mechanisms of obesity-induced hypertension: role of adipose tissue. Curr Hypertens Rep 2001; 3: 152\u2013156.","journal-title":"Curr Hypertens Rep"},{"key":"BF1001877_CR3","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0889-8529(03)00073-2","volume":"32","author":"BV Howard","year":"2003","unstructured":"Howard BV, Ruotolo G, Robbins DC . Obesity and dyslipidemia. Endocrinol Metab Clin North Am 2003; 32: 855\u2013867.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"Suppl 1","key":"BF1001877_CR4","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1097\/00005344-199306221-00003","volume":"22","author":"FH Messerli","year":"1993","unstructured":"Messerli FH, Ketelhut R . Left ventricular hypertrophy: a pressure-independent cardiovascular risk factor. J Cardiovasc Pharmacol 1993; 22(Suppl 1): S7\u2013S13.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF1001877_CR5","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1093\/ajcn\/56.2.320","volume":"56","author":"AM Dattilo","year":"1992","unstructured":"Dattilo AM, Kris-Etherton PM . Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 1992; 56: 320\u2013328.","journal-title":"Am J Clin Nutr"},{"key":"BF1001877_CR6","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1067\/mhj.2002.124403","volume":"144","author":"F Zannad","year":"2002","unstructured":"Zannad F et al. Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction. Am Heart J 2002; 144: 508\u2013515.","journal-title":"Am Heart J"},{"key":"BF1001877_CR7","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1055\/s-2002-22671","volume":"127","author":"J Scholtze","year":"2002","unstructured":"Scholtze J . Treating obesity with sibutramine under practical conditions. Positive effects on the metabolic parameters and blood pressure (English translation). Dtsh Med Wochenschr 2002; 127: 606\u2013610.","journal-title":"Dtsh Med Wochenschr"},{"key":"BF1001877_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/oby.2000.32","volume":"8","author":"IL Mertens","year":"2000","unstructured":"Mertens IL, Van Gaal LF . Overweight, obesity, and blood pressure: the effects of modest weight reduction. Obes Res 2000; 8: 270\u2013278.","journal-title":"Obes Res"},{"key":"BF1001877_CR9","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1056\/NEJM198104163041602","volume":"304","author":"ML Tuck","year":"1981","unstructured":"Tuck ML et al. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 1981; 304: 930\u2013933.","journal-title":"N Engl J Med"},{"key":"BF1001877_CR10","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/archinte.1990.00040031701019","volume":"150","author":"DE Schotte","year":"1990","unstructured":"Schotte DE, Stunkard AJ . The effects of weight reduction on blood pressure in 301 obese patients. Arch Intern Med 1990; 150: 1701\u20131704.","journal-title":"Arch Intern Med"},{"key":"BF1001877_CR11","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/sj.ijo.0801059","volume":"23","author":"DL Hansen","year":"1999","unstructured":"Hansen DL et al. The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction. Int J Obes Relat Metab Disord 1999; 23: 1016\u20131024.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF1001877_CR12","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/sj.ijo.0801045","volume":"23","author":"KM Walsh","year":"1999","unstructured":"Walsh KM, Leen E, Lean MEJ . The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females. Int J Obes Relat Metab Disord 1999; 23: 1009\u20131015.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF1001877_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/j.1550-8528.1999.tb00701.x","volume":"7","author":"GA Bray","year":"1999","unstructured":"Bray GA et al. Sibutramine produces dose-related weight loss. Obes Res 1999; 7: 189\u2013198.","journal-title":"Obes Res"},{"key":"BF1001877_CR14","unstructured":"Package insert. Reductil\/Meridia (sibutramine). Abbott Laboratories, 2004."},{"key":"BF1001877_CR15","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1001\/archinte.160.14.2185","volume":"160","author":"FG MacMahon","year":"2000","unstructured":"MacMahon FG et al. Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial. Arch Intern Med 2000; 160: 2185\u20132191.","journal-title":"Arch Intern Med"},{"key":"BF1001877_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/sj.jhh.1001298","volume":"16","author":"FG McMahon","year":"2002","unstructured":"McMahon FG et al. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors. J Hum Hypertens 2002; 16: 5\u201311.","journal-title":"J Hum Hypertens"},{"key":"BF1001877_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/sj.jhh.1001299","volume":"16","author":"JJ Sramek","year":"2002","unstructured":"Sramek JJ et al. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by \u03b2-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial. J Hum Hypertens 2002; 16: 13\u201319.","journal-title":"J Hum Hypertens"},{"key":"#cr-split#-BF1001877_CR18.1","unstructured":"World Health Organization (homepage on the Internet), Geneva, Switzerland (updated 2003 March 9"},{"key":"#cr-split#-BF1001877_CR18.2","unstructured":"cited 2004 December 13). Available from http:\/\/www.who.int\/nut\/obs.htm."},{"key":"BF1001877_CR19","unstructured":"World Health Organization. World Health Report 2002: Reducing Risks, Promoting Healthy Life. Executive Summary. WHO Publications, Geneva, 2002, p 1."},{"key":"BF1001877_CR20","unstructured":"World Health Organization. Obesity: Preventing and Managing the Global Epidemic, Report of World Health Organization Consultation on Obesity, Executive Summary. Technical Report Series. WHO Publications, Geneva, 2000, p 1."},{"key":"BF1001877_CR21","unstructured":"World Health Organization. World Health Report 2002: Reducing Risks, Promoting Healthy Life. WHO Publications, Geneva, 2002, p 8."},{"key":"BF1001877_CR22","unstructured":"World Health Organization Report. Obesity: Preventing and Managing the Global Epidemic. Technical Report Series. WHO Publications, Geneva, 2000, p 25."},{"key":"BF1001877_CR23","unstructured":"International Obesity Task Force [homepage on the Internet]. London, UK. Link: About Obesity. Page: The Developing World's New Burden: Obesity [cited 2004 Dec 13]. Available from: www.iotf.org."},{"key":"BF1001877_CR24","unstructured":"National Institutes of Health; National Heart, Lung, and Blood Institute; North American Association for the Study of Obesity. The Practical Guide 2000, p 5."},{"key":"BF1001877_CR25","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1001\/jama.286.11.1331","volume":"286","author":"A Wirth","year":"2001","unstructured":"Wirth A, Krause J . Long-term weight loss with sibutramine: a randomized controlled trial. JAMA 2001; 286: 1331\u20131339.","journal-title":"JAMA"},{"key":"BF1001877_CR26","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","volume":"344","author":"J Tuomilehto","year":"2001","unstructured":"Tuomilehto J et al. Prevention of type II diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Eng J Med 2001; 344: 1343\u20131350.","journal-title":"N Eng J Med"},{"key":"BF1001877_CR27","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/oxfordjournals.aje.a117386","volume":"141","author":"DF Williamson","year":"1995","unstructured":"Williamson DF . Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40\u201364 years. Am J Epidemiol 1995; 141: 1128\u20131141; Erratum, Am J Epidemiol 1995;142:369.","journal-title":"Am J Epidemiol"},{"key":"BF1001877_CR28","unstructured":"World Health Organization Report. Obesity: Preventing and Managing the Global Epidemic. Technical Report Series. WHO Publications, Geneva, 2000, p 70."},{"key":"BF1001877_CR29","doi-asserted-by":"crossref","unstructured":"National Task Force on the Prevention and Treatment of Obesity. Long-term pharmacotherapy in the management of obesity. JAMA 1996; 276: 1907\u20131908.","DOI":"10.1001\/jama.1996.03540230057036"},{"issue":"Suppl 2","key":"BF1001877_CR30","first-page":"S104","volume":"25","author":"A Astrup","year":"2001","unstructured":"Astrup A, Chong E . Weight loss produced by sibutramine: a meta-analysis (abstract). Int J Obes Relat Metab Disord 2001; 25(Suppl 2): S104.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF1001877_CR31","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","volume":"356","author":"WPT James","year":"2000","unstructured":"James WPT et al. Effect of sibutramine on weight maintenance after weight loss: a randomized trial. Lancet 2000; 356: 2119\u20132125.","journal-title":"Lancet"},{"key":"BF1001877_CR32","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","volume":"356","author":"WPT James","year":"2000","unstructured":"James WPT et al. Effect of sibutramine on weight maintenance after weight loss: a randomized trial (STORM). Lancet 2000; 356: 2119\u20132125.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"BF1001877_CR33","first-page":"S30","volume":"21","author":"ME Lean","year":"1997","unstructured":"Lean ME . Sibutramine \u2014 a review of clinical efficacy (review). Int J Obes Relat Metab Disord 1997; 21(Suppl 1): S30\u2013S36; discussion 37\u201339.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"Suppl 4","key":"BF1001877_CR34","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1038\/sj.ijo.0801934","volume":"25","author":"AM Sharma","year":"2001","unstructured":"Sharma AM . Sibutramine in overweight\/obese hypertensive patients. Int J Obes Relat Metab Disord 2001; 25(Suppl 4): S20\u2013S23.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF1001877_CR35","doi-asserted-by":"crossref","unstructured":"National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039.","DOI":"10.2337\/diab.28.12.1039"},{"key":"BF1001877_CR36","first-page":"505","volume":"50","author":"IG Smith","year":"2001","unstructured":"Smith IG, Goulder MA . Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity. J Fam Pract 2001; 50: 505\u2013512.","journal-title":"J Fam Pract"},{"key":"BF1001877_CR37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0002-9343(98)00411-2","volume":"106","author":"M Apfelbaum","year":"1999","unstructured":"Apfelbaum M et al. Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine. Am J Med 1999; 106: 179\u2013184.","journal-title":"Am J Med"},{"key":"BF1001877_CR38","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2337\/diacare.10.5.563","volume":"10","author":"RR Wing","year":"1987","unstructured":"Wing RR, Marcus MD, Epstein LH, Salata R . Type II diabetic subjects lose less weight than their overweight nondiabetic spouses. Diabetes Care 1987; 10: 563\u2013566.","journal-title":"Diabetes Care"},{"key":"BF1001877_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1046\/j.1463-1326.2000.00071.x","volume":"2","author":"N Finer","year":"2000","unstructured":"Finer N et al. Sibutramine is effective for weight loss and diabetic control in obesity with type II diabetes: a randomised, double-blind, placebo-controlled study. Diabetes Obes Metab 2000; 2: 105\u2013112.","journal-title":"Diabetes Obes Metab"},{"key":"BF1001877_CR40","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.clinthera.2004.09.017","volume":"26","author":"L Sanchez-Reyes","year":"2004","unstructured":"Sanchez-Reyes L et al. Use of sibutramine in overweight adult Hispanic patients with type II diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial. Clin Ther 2004; 26: 1427\u20131435.","journal-title":"Clin Ther"},{"key":"BF1001877_CR41","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2337\/diacare.26.1.125","volume":"26","author":"SJ McNulty","year":"2003","unstructured":"McNulty SJ, Ur E, Williams G . A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin. Diabetes Care 2003; 26: 125\u2013131.","journal-title":"Diabetes Care"},{"key":"BF1001877_CR42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1046\/j.1464-5491.2002.00655.x","volume":"19","author":"M Serrano-Rios","year":"2002","unstructured":"Serrano-Rios M, Melchionda N, Moreno-Carretero E . Role of sibutramine in the treatment of obese type 2 diabetic patients receiving sulphonylurea therapy. Diabet Med 2002; 19: 119\u2013124.","journal-title":"Diabet Med"},{"key":"BF1001877_CR43","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","volume":"356","author":"WPT James","year":"2000","unstructured":"James WPT et al. Effect of sibutramine on weight maintenance after weight loss: a randomized trial (STORM). Lancet 2000; 356: 2119\u20132125.","journal-title":"Lancet"},{"issue":"Supp 1","key":"BF1001877_CR44","first-page":"S30","volume":"21","author":"ME Lean","year":"1997","unstructured":"Lean ME . Sibutramine \u2014 a review of clinical efficacy (review). Int J Obes Relat Metab Disord 1997; 21(Supp 1): S30\u2013S36; discussion 37\u201339.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"Suppl 4","key":"BF1001877_CR45","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1038\/sj.ijo.0801934","volume":"25","author":"AM Sharma","year":"2001","unstructured":"Sharma AM . Sibutramine in overweight\/obese hypertensive patients. Int J Obes Relat Metab Disord 2001; 25(Suppl 4): S20\u2013S23.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"Suppl 9","key":"BF1001877_CR46","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/archinte.164.9.994","volume":"164","author":"DE Arterburn","year":"2004","unstructured":"Arterburn DE, Crane PK, Veenstra DL . The efficacy and safety of sibutramine for weight loss: a systematic review. Arch Intern Med 2004; 164(Suppl 9): 994\u20131003.","journal-title":"Arch Intern Med"},{"issue":"Suppl 4","key":"BF1001877_CR47","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1038\/sj.ijo.0802218","volume":"26","author":"K Narkiewicz","year":"2002","unstructured":"Narkiewicz K . Sibutramine and its cardiovascular profile. Int J Obes Relat Metab Disord 2002; 26(Suppl 4): S38\u2013S41.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF1001877_CR48","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1161\/01.CIR.0000036370.31856.73","volume":"106","author":"AL Birkenfeld","year":"2002","unstructured":"Birkenfeld AL et al. Paradoxical effect of sibutramine on autonomic cardiovascular regulation. Circulation 2002; 106: 2459\u20132465.","journal-title":"Circulation"},{"key":"BF1001877_CR49","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1210\/jc.2004-0263","volume":"90","author":"A Godoy-Matos","year":"2005","unstructured":"Godoy-Matos A . Treatment of obese adolescents with sibutramine: a randomized, double-blind, controlled study. J Clin Endocrinol Metab 2005; 90: 1460\u20131465.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF1001877_CR50","doi-asserted-by":"crossref","unstructured":"Jordan J et al. Influence of sibutramine on blood pressure: evidence from placebo-controlled trials. Int J Obes Relat Metab Disord (Advance E-pub) 2005; doi 10.1038\/sj.ijo.0802887.","DOI":"10.1038\/sj.ijo.0802887"},{"key":"BF1001877_CR51","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000047310","volume":"94","author":"BP Hazenberg","year":"2000","unstructured":"Hazenberg BP . Randomized, double-blind, placebo-controlled, multicenter study of sibutramine in obese hypertensive patients. Cardiology 2000; 94: 152\u2013158.","journal-title":"Cardiology"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1001877.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1001877","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1001877.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T10:21:30Z","timestamp":1647512490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1001877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,19]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9,1]]}},"alternative-id":["BF1001877"],"URL":"https:\/\/doi.org\/10.1038\/sj.jhh.1001877","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,19]]},"assertion":[{"value":"3 December 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2005","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2005","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2005","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}